COVID-19 information links for 2020:
The Coventry & Warwickshire Formulary has been developed through wide consultation with stakeholders in both primary and secondary care which has delivered an initial version covering over 40 sections and sub-sections of the BNF. The formulary will be a dynamic list of drugs considered as the most cost-effective alternatives in each section, the decision underpinned by high grade evidence, and changes will be made as the evidence base alters and/or costs change.
| These are important APC outputs as they guide all prescribers, in secondary and primary care, to those drugs which are considered as “specialist” and into which category they have been placed. The four categories are: SI , SA , SC , SO for explanation of these terms refer to netFormulary end pages when searching for drug/product entry. |
Prescribers should always default to the generic version of the drug, and the formulary uses the approved generic names for all preferred and second-line choices, except in the following circumstances;